Elsbernd Brian bought CPRX
November 12, 2025 · Form 4 insider transaction
Elsbernd Brian bought 40,000 shares of Catalyst Pharmaceuticals Inc at $22.70 per share, a transaction worth $908.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$22.70
Total value
$908.0K
InsiderElsbernd Brian
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeS: Open-market sale
Transaction dateNovember 12, 2025
Filing dateNovember 14, 2025
Shares owned after231,039
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold for personal reasons and not as a result of any disagreement with the Company.; Represents a weighted average price for the shares sold. Shares were sold in a range from $22.55 to $23.00 per share.